Bondarenko, M.; Le Grand, M.; Shaked, Y.; Raviv, Z.; Chapuisat, G.; Carrère, C.; Montero, M.-P.; Rossi, M.; Pasquier, E.; Carré, M.;
et al. Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer. Cancers 2021, 13, 2239.
https://doi.org/10.3390/cancers13092239
AMA Style
Bondarenko M, Le Grand M, Shaked Y, Raviv Z, Chapuisat G, Carrère C, Montero M-P, Rossi M, Pasquier E, Carré M,
et al. Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer. Cancers. 2021; 13(9):2239.
https://doi.org/10.3390/cancers13092239
Chicago/Turabian Style
Bondarenko, Maryna, Marion Le Grand, Yuval Shaked, Ziv Raviv, Guillemette Chapuisat, Cécile Carrère, Marie-Pierre Montero, Mailys Rossi, Eddy Pasquier, Manon Carré,
and et al. 2021. "Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer" Cancers 13, no. 9: 2239.
https://doi.org/10.3390/cancers13092239
APA Style
Bondarenko, M., Le Grand, M., Shaked, Y., Raviv, Z., Chapuisat, G., Carrère, C., Montero, M. -P., Rossi, M., Pasquier, E., Carré, M., & André, N.
(2021). Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer. Cancers, 13(9), 2239.
https://doi.org/10.3390/cancers13092239